This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.
The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.
Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.
Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across law and emerging technologies.
Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and is listed among the world’s Top 2% Scientists per Stanford University.
Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on intellectual property and emerging technologies, particularly artificial intelligence and innovation policy.
Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, UAE, with over 25 years of experience in clinical pharmacy and pharmacovigilance research.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide. Discusses trends in biomedical research on the integration of genome editing and its potential benefits in medicine and the healthcare industry. Explores the advent of technologies, such as CRISPR-Cas-9, TALENs, and ZFNs Covers their mechanisms of action and how effectively they can help machinery to overcome genetic failures. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781779643810
Quantité disponible : 1 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Hardcover. Etat : new. Hardcover. This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide. Discusses trends in biomedical research on the integration of genome editing and its potential benefits in medicine and the healthcare industry. Explores the advent of technologies, such as CRISPR-Cas-9, TALENs, and ZFNs Covers their mechanisms of action and how effectively they can help machinery to overcome genetic failures. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9781779643810
Quantité disponible : 1 disponible(s)
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9781779643810
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L1-9781779643810
Quantité disponible : Plus de 20 disponibles
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Hardcover. Etat : new. Hardcover. This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide. Discusses trends in biomedical research on the integration of genome editing and its potential benefits in medicine and the healthcare industry. Explores the advent of technologies, such as CRISPR-Cas-9, TALENs, and ZFNs Covers their mechanisms of action and how effectively they can help machinery to overcome genetic failures. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9781779643810
Quantité disponible : 1 disponible(s)
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L1-9781779643810
Quantité disponible : Plus de 20 disponibles
Vendeur : moluna, Greven, Allemagne
Etat : New. Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across la. N° de réf. du vendeur 3236079224
Quantité disponible : Plus de 20 disponibles
Vendeur : preigu, Osnabrück, Allemagne
Buch. Etat : Neu. Genetic Editing for Healthcare | Advances in Disease Management | Bhupinder Singh (u. a.) | Buch | Einband - fest (Hardcover) | Englisch | 2026 | Apple Academic Press | EAN 9781779643810 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 135961310
Quantité disponible : 5 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. Neuware - This book presents a focused and timely exploration of genome editing and its transformative impact on modern medicine. Integrating interdisciplinary perspectives, the volume examines how emerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complex diseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9, TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role in biomedical research. It then moves to practical applications, highlighting case studies in areas such as cancer treatment and precision medicine, demonstrating how gene-editing technologies are improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatory considerations, including biosafety, intellectual property, and human rights. By examining both opportunities and challenges, it emphasizes the need for responsible and well-regulated implementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balanced perspective on the evolving role of genome editing in advancing healthcare worldwide. N° de réf. du vendeur 9781779643810
Quantité disponible : 2 disponible(s)